Cann Group Ltd - Asset Resilience Ratio

Latest as of June 2025: 0.01%

Cann Group Ltd (CAN) has an Asset Resilience Ratio of 0.01% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Cann Group Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

AU$10.00K

≈ $7.08K USD Cash + Short-term Investments

Total Assets

AU$78.79 Million

≈ $55.75 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Cann Group Ltd's Asset Resilience Ratio has changed over time. See net assets of Cann Group Ltd for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Cann Group Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Cann Group Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$10.00K	0.01%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$10.00K	0.01%

Asset Resilience Insights

Limited Liquidity: Cann Group Ltd maintains only 0.01% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Cann Group Ltd Industry Peers by Asset Resilience Ratio

Compare Cann Group Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Daihan Pharmaceutical Co.Ltd KQ:023910	Drug Manufacturers - Specialty & Generic	11.95%
Aurobindo Pharma Limited NSE:AUROPHARMA	Drug Manufacturers - Specialty & Generic	16.92%
China Resources Sanjiu Medical & Pharmaceutical Co Ltd SHE:000999	Drug Manufacturers - Specialty & Generic	5.22%
Ningbo Menovo Pharm Co Ltd SHG:603538	Drug Manufacturers - Specialty & Generic	2.69%
Zhejiang Xianju Pharmaceutical Co Ltd SHE:002332	Drug Manufacturers - Specialty & Generic	6.02%
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	Drug Manufacturers - Specialty & Generic	30.38%
Hainan Honz Pharmaceutical Co SHE:300086	Drug Manufacturers - Specialty & Generic	0.27%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%

Annual Asset Resilience Ratio for Cann Group Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Cann Group Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	0.01%	AU$10.00K ≈ $7.08K	AU$78.79 Million ≈ $55.75 Million	-1.76pp
2024-06-30	1.77%	AU$1.64 Million ≈ $1.16 Million	AU$92.77 Million ≈ $65.64 Million	+1.18pp
2023-06-30	0.59%	AU$765.00K ≈ $541.29K	AU$129.47 Million ≈ $91.61 Million	-0.78pp
2022-06-30	1.37%	AU$1.91 Million ≈ $1.35 Million	AU$139.66 Million ≈ $98.82 Million	-1.60pp
2021-06-30	2.97%	AU$3.02 Million ≈ $2.14 Million	AU$101.79 Million ≈ $72.02 Million	+1.04pp
2020-06-30	1.92%	AU$1.47 Million ≈ $1.04 Million	AU$76.40 Million ≈ $54.06 Million	-54.57pp
2019-06-30	56.49%	AU$46.39 Million ≈ $32.82 Million	AU$82.11 Million ≈ $58.10 Million	-35.27pp
2018-06-30	91.76%	AU$79.65 Million ≈ $56.36 Million	AU$86.80 Million ≈ $61.42 Million	+18.03pp
2017-06-30	73.73%	AU$11.11 Million ≈ $7.86 Million	AU$15.07 Million ≈ $10.67 Million	--
2016-12-31	0.00%	AU$0.00 ≈ $0.00	AU$15.89 Million ≈ $11.25 Million	--

pp = percentage points

About Cann Group Ltd

AU:CAN Australia Drug Manufacturers - Specialty & Generic

Market Cap

$5.62 Million

AU$7.94 Million AUD

Market Cap Rank

#28131 Global

#1532 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.02

All Time High

AU$3.98